27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Bristol-Myers Squibb Co (NYSE:BMY) shares are trading about unchanged at $55.95 in Wednesday's session.
At this time, investors aren't too impressed that its study for Opdivo met its primary endpoint. The drug has become an important treatment option for multiple cancers.
After a flat open, Bristol-Myers could only rally another 7 cents to $56.34 before reversing course. The ensuing decline found intraday support in a familiar area. Its current low of $55.55 comes in between its June 29 ($55.49) and June 30 ($55.68) lows.
Excluding Monday's close of $56.27, the stock's four previous closes came within a narrow range of $55.72 to $55.90.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!